Clinical trials: Amygdala Activation
Specific Phobia
Quetiapine in Specific Phobia
The study hypothesis is that quetiapine XR has anxiolytic properties. The study aims to investigate the putative anxiolytic properties of quetiapine XR in patients with anxiety disorders.
- Trial name
- QUISS (NCT00872716)
- Testing
- Quetiapine XR
- Where
- Germany
- Volunteers
- 60 people
- Sponsor
- University Hospital Muenster
Stress Disorders, Post-Traumatic
Brain Structure and Function Before and After Treatment for Post-Traumatic Stress Disorder
This study, conducted at the University of Pennsylvania and at the National Institutes of Health in Bethesda, Maryland, will examine deficits in brain structure and function in people exposed to trauma who developed…
- Trial name
- NCT00069225
- Where
- United States
- Volunteers
- 95 people, healthy volunteers welcome
- Sponsor
- National Institute of Mental Health (NIMH)
Post Traumatic Stress Disorder
The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
This study aims to investigate the effects of MDMA on prefrontal and amygdala activation, and to explore the relationship between these MDMA-induced neural changes and the acute behavioral effects of the drug in patients with…
- Trial name
- NCT03752918
- Testing
- MDMA, Niacin
- Where
- United States
- Sponsor
- Yale University
Amygdala Activation
Effects of Connectivity-based rTMS and State-Dependency on Amygdala Activation
Posttraumatic stress disorder (PTSD) is a highly debilitating disease with response rates to pharmacological treatment rarely exceeding 60%.
- Trial name
- ConnecTMS (NCT03746405)
- Testing
- repetitive transcranial magnetic stimulation
- Where
- United States
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- Duke University